Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Total Liabilities (2020 - 2025)

Historic Total Liabilities for Cellebrite DI (CLBT) over the last 6 years, with Q3 2025 value amounting to $386.6 million.

  • Cellebrite DI's Total Liabilities rose 1683.26% to $386.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $386.6 million, marking a year-over-year increase of 1683.26%. This contributed to the annual value of $354.5 million for FY2024, which is 2890.19% down from last year.
  • Cellebrite DI's Total Liabilities amounted to $386.6 million in Q3 2025, which was up 1683.26% from $379.0 million recorded in Q2 2025.
  • Cellebrite DI's Total Liabilities' 5-year high stood at $596.7 million during Q2 2024, with a 5-year trough of $293.0 million in Q3 2022.
  • Moreover, its 5-year median value for Total Liabilities was $379.0 million (2025), whereas its average is $399.3 million.
  • Per our database at Business Quant, Cellebrite DI's Total Liabilities skyrocketed by 10720.94% in 2021 and then crashed by 3768.06% in 2025.
  • Quarter analysis of 5 years shows Cellebrite DI's Total Liabilities stood at $413.1 million in 2021, then fell by 20.26% to $329.4 million in 2022, then surged by 51.38% to $498.7 million in 2023, then dropped by 28.9% to $354.5 million in 2024, then increased by 9.05% to $386.6 million in 2025.
  • Its Total Liabilities stands at $386.6 million for Q3 2025, versus $379.0 million for Q2 2025 and $346.4 million for Q1 2025.